Derek J Dean1, Joseph M Orr2, Jessica A Bernard3, Tina Gupta3, Andrea Pelletier-Baldelli4, Emily E Carol3, Vijay A Mittal5. 1. Department of Psychology and Neuroscience, Center for Neuroscience, and derek.dean@colorado.edu. 2. Institute for Cognitive Science, University of Colorado Boulder, Boulder, CO; 3. Department of Psychology and Neuroscience. 4. Department of Psychology and Neuroscience, Center for Neuroscience, and. 5. Department of Psychology, Northwestern University, Evanston, IL.
Abstract
INTRODUCTION: Hippocampal abnormalities have been widely studied in schizophrenia spectrum populations including those at ultrahigh risk (UHR) for psychosis. There have been inconsistent findings concerning hippocampal morphology prior to and during the transition to psychosis, and little is known about how specific subregions are related to the symptom progression. METHODS: A total of 80 participants (38 UHR and 42 healthy controls) underwent a 3T MRI scan, as well as structured clinical interviews. Shape analysis of hippocampi was conducted with FSL/FIRST vertex analysis to yield a localized measure of shape differences between groups. A subgroup of the sample (24 UHR and 24 controls) also returned for a 12-month clinical follow-up assessment. RESULTS: The UHR group exhibited smaller hippocampal volumes bilaterally, and shape analysis revealed significant inversion in the left ventral posterior hippocampus in the UHR group. Greater inversion in this subregion was related to elevated symptomatology at baseline and increased positive symptoms, negative symptoms, and impaired tolerance to normal stress 12 months later. These results did not hold when left hippocampal volume was used as a predictor instead. DISCUSSION: This represents the first study to use vertex analysis in a UHR sample and results suggest that abnormalities in hippocampal shape appear to reflect underlying pathogenic processes driving the progression of illness. These findings suggest that examining shape and volume may provide an important new perspective for our conception of brain alterations in the UHR period.
INTRODUCTION: Hippocampal abnormalities have been widely studied in schizophrenia spectrum populations including those at ultrahigh risk (UHR) for psychosis. There have been inconsistent findings concerning hippocampal morphology prior to and during the transition to psychosis, and little is known about how specific subregions are related to the symptom progression. METHODS: A total of 80 participants (38 UHR and 42 healthy controls) underwent a 3T MRI scan, as well as structured clinical interviews. Shape analysis of hippocampi was conducted with FSL/FIRST vertex analysis to yield a localized measure of shape differences between groups. A subgroup of the sample (24 UHR and 24 controls) also returned for a 12-month clinical follow-up assessment. RESULTS: The UHR group exhibited smaller hippocampal volumes bilaterally, and shape analysis revealed significant inversion in the left ventral posterior hippocampus in the UHR group. Greater inversion in this subregion was related to elevated symptomatology at baseline and increased positive symptoms, negative symptoms, and impaired tolerance to normal stress 12 months later. These results did not hold when left hippocampal volume was used as a predictor instead. DISCUSSION: This represents the first study to use vertex analysis in a UHR sample and results suggest that abnormalities in hippocampal shape appear to reflect underlying pathogenic processes driving the progression of illness. These findings suggest that examining shape and volume may provide an important new perspective for our conception of brain alterations in the UHR period.
Authors: Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale Journal: Neuron Date: 2002-01-31 Impact factor: 17.173
Authors: Lisa J Phillips; Dennis Velakoulis; Christos Pantelis; Stephen Wood; Hok Pan Yuen; Alison R Yung; Patricia Desmond; Warrick Brewer; Patrick D McGorry Journal: Schizophr Res Date: 2002-12-01 Impact factor: 4.939
Authors: John G Csernansky; Lei Wang; Donald Jones; Devna Rastogi-Cruz; Joel A Posener; Gitry Heydebrand; J Philip Miller; Michael I Miller Journal: Am J Psychiatry Date: 2002-12 Impact factor: 18.112
Authors: Theo G M Van Erp; Peter A Saleh; Isabelle M Rosso; Matti Huttunen; Jouko Lönnqvist; Tiia Pirkola; Oili Salonen; Leena Valanne; Veli-Pekka Poutanen; Carl-Gustav Standertskjöld-Nordenstam; Tyrone D Cannon Journal: Am J Psychiatry Date: 2002-09 Impact factor: 18.112
Authors: Stephen M Lawrie; Heather C Whalley; Suheib S Abukmeil; Julia N Kestelman; Patrick Miller; Jonathan J K Best; David G C Owens; Eve C Johnstone Journal: Br J Psychiatry Date: 2002-08 Impact factor: 9.319
Authors: Theodore D Satterthwaite; Daniel H Wolf; Monica E Calkins; Simon N Vandekar; Guray Erus; Kosha Ruparel; David R Roalf; Kristin A Linn; Mark A Elliott; Tyler M Moore; Hakon Hakonarson; Russell T Shinohara; Christos Davatzikos; Ruben C Gur; Raquel E Gur Journal: JAMA Psychiatry Date: 2016-05-01 Impact factor: 21.596
Authors: James K Ruffle; Steven J Coen; Vincent Giampietro; Steven C R Williams; A Vania Apkarian; Adam D Farmer; Qasim Aziz Journal: Hum Brain Mapp Date: 2017-10-28 Impact factor: 5.038
Authors: Nina Vanessa Kraguljac; David Matthew White; Nathan Hadley; Jennifer Ann Hadley; Lawrence Ver Hoef; Ebony Davis; Adrienne Carol Lahti Journal: Schizophr Bull Date: 2016-02-12 Impact factor: 9.306
Authors: David R Roalf; Megan Quarmley; Monica E Calkins; Theodore D Satterthwaite; Kosha Ruparel; Mark A Elliott; Tyler M Moore; Ruben C Gur; Raquel E Gur; Paul J Moberg; Bruce I Turetsky Journal: Schizophr Bull Date: 2017-05-01 Impact factor: 9.306
Authors: Sina Hafizi; Elisa Guma; Alex Koppel; Tania Da Silva; Michael Kiang; Sylvain Houle; Alan A Wilson; Pablo M Rusjan; M Mallar Chakravarty; Romina Mizrahi Journal: Brain Behav Immun Date: 2018-06-12 Impact factor: 7.217